Skip to content

Commit

Permalink
Prettier write fix
Browse files Browse the repository at this point in the history
  • Loading branch information
@danilomartinss
danilomartinss committed Dec 13, 2024
1 parent 988cd88 commit 89a2a37
Showing 1 changed file with 67 additions and 42 deletions.
109 changes: 67 additions & 42 deletions src/app/topics/mycoplasma/page.tsx
View file
Original file line number Diff line number Diff line change
Expand Up @@ -11,7 +11,8 @@ import CentralImage from "@/components/central-image";
const resources: CardGridData[] = [
{
title: "FHI - Folkehelseinstituttet",
description: "Mycoplasma pneumoniae infections - handbook for health professionals.",
description:
"Mycoplasma pneumoniae infections - handbook for health professionals.",
link: "https://www.fhi.no/sm/smittevernhandboka/sykdommer-a-a/mycoplasma-pneumoniae-infeksjoner/?term=",
image: "/logos/FHI.png",
},
Expand All @@ -23,7 +24,8 @@ const resources: CardGridData[] = [
},
{
title: "FHI - Folkehelseinstituttet",
description: "Weekly summaries and graphs of samples with respectively detected respiratory viruses and detected respiratory bacteria",
description:
"Weekly summaries and graphs of samples with respectively detected respiratory viruses and detected respiratory bacteria",
link: "https://www.fhi.no/publ/statusrapporter/luftveisinfeksjoner/",
image: "/logos/FHI.png",
},
Expand Down Expand Up @@ -60,36 +62,42 @@ export default function MpoxPage() {
<HoverCardContent>Generate by AI</HoverCardContent>
</HoverCard>
<p className="text-justify">
<strong>Mycoplasma</strong> are small, typically between 0.1 to 0.3 micrometers in diameter,
and are pleomorphic, meaning they can vary in shape example: spherical, ovoid,
or even branched under a microscope. This feature allows them to squeeze through
tight spaces and avoid some antibiotics, especially those that target cell walls,
like penicillin. They are unique in that they lack a cell wall, unlike most
<strong>Mycoplasma</strong> are small, typically between 0.1 to 0.3
micrometers in diameter, and are pleomorphic, meaning they can vary in
shape example: spherical, ovoid, or even branched under a microscope.
This feature allows them to squeeze through tight spaces and avoid
some antibiotics, especially those that target cell walls, like
penicillin. They are unique in that they lack a cell wall, unlike most
bacteria, which gives them unusual flexibility and resilience.
</p>
<p className="text-justify">
<strong><i>Mycoplasma pneumoniae</i></strong> infections have been on the
rise in Europe, including Norway, following a recent trend of increased
cases across multiple countries <strong>(Figure 1)</strong>. Known for
causing respiratory infections such as &quot;walking pneumonia&quot;,{" "}
<i>Mycoplasma pneumoniae</i> primarily affects children and young adults
and often results in mild symptoms like a persistent cough and fever.
Recently, however, some regions have reported more severe symptoms and a
notable rise in hospital visits due to complications, particularly in
younger children under age five, a demographic not typically as impacted
by Mycoplasma infections in the past.
<strong>
<i>Mycoplasma pneumoniae</i>
</strong>{" "}
infections have been on the rise in Europe, including Norway,
following a recent trend of increased cases across multiple countries{" "}
<strong>(Figure 1)</strong>. Known for causing respiratory infections
such as &quot;walking pneumonia&quot;, <i>Mycoplasma pneumoniae</i>{" "}
primarily affects children and young adults and often results in mild
symptoms like a persistent cough and fever. Recently, however, some
regions have reported more severe symptoms and a notable rise in
hospital visits due to complications, particularly in younger children
under age five, a demographic not typically as impacted by Mycoplasma
infections in the past.
</p>
<p className="text-justify">
In Norway, public health authorities are closely monitoring the situation
and coordinating with European and U.S. health agencies to understand the
potential for antibiotic resistance in these cases. While <i>Mycoplasma pneumoniae</i>
infections are usually treated with macrolides,
resistance to these antibiotics has been observed, particularly in regions
like Asia and occasionally in the United States and Europe. Norway&#39;s
health services are advising vigilance in monitoring symptoms and have
issued guidance on treatment practices to address this emerging resistance concern.
In Norway, public health authorities are closely monitoring the
situation and coordinating with European and U.S. health agencies to
understand the potential for antibiotic resistance in these cases.
While <i>Mycoplasma pneumoniae</i>
infections are usually treated with macrolides, resistance to these
antibiotics has been observed, particularly in regions like Asia and
occasionally in the United States and Europe. Norway&#39;s health
services are advising vigilance in monitoring symptoms and have issued
guidance on treatment practices to address this emerging resistance
concern.
</p>

<HoverCard>
<HoverCardTrigger asChild>
<CentralImage
Expand All @@ -98,40 +106,57 @@ export default function MpoxPage() {
/>
</HoverCardTrigger>
<HoverCardContent className="w-[400px]">
Figure 1. Number of detections of Mycoplasma pneumoniae per week, 3 January 2022 - 18 August 2024. Source: FHI, MSIS lab database.
Figure 1. Number of detections of Mycoplasma pneumoniae per week, 3
January 2022 - 18 August 2024. Source: FHI, MSIS lab database.
</HoverCardContent>
</HoverCard>

<h2 className="text-2xl font-bold"><strong><i>Mycoplasma pneumoniae</i></strong> facts in Norway</h2>
<h3 className="text-2xl font-bold"><strong>Outbreak Overview</strong></h3>
<h2 className="text-2xl font-bold">
<strong>
<i>Mycoplasma pneumoniae</i>
</strong>{" "}
facts in Norway
</h2>
<h3 className="text-2xl font-bold">
<strong>Outbreak Overview</strong>
</h3>
<ul className="flex flex-col space-y-1">
<li>
Norway is currently experiencing a significant outbreak of <i>Mycoplasma pneumoniae</i>.
Norway is currently experiencing a significant outbreak of{" "}
<i>Mycoplasma pneumoniae</i>.
</li>
<li>
The outbreak began intensifying in <strong>late summer 2023</strong> and has continued
into <strong>2024</strong>.
The outbreak began intensifying in <strong>late summer 2023</strong>{" "}
and has continued into <strong>2024</strong>.
</li>
<li>
There is over <strong>3,500</strong> cases detected since the beginning of July 2023.
The most affected groups are school children between 5-14 years old. However, there
is significant number of hospitalized young adults.
There is over <strong>3,500</strong> cases detected since the
beginning of July 2023. The most affected groups are school children
between 5-14 years old. However, there is significant number of
hospitalized young adults.
</li>
<li>
The common symptoms are general cold-like symptoms and persistent cough.
The common symptoms are general cold-like symptoms and persistent
cough.
</li>
</ul>

<h3 className="text-2xl font-bold"><strong>Antibiotic Resistance Concerns</strong></h3>
<h3 className="text-2xl font-bold">
<strong>Antibiotic Resistance Concerns</strong>
</h3>
<p className="text-justify">
There is growing concern about resistance to macrolide antibiotics (e.g., azithromycin),
the first-line treatment for <i>Mycoplasma pneumoniae</i>.
There is growing concern about resistance to macrolide antibiotics
(e.g., azithromycin), the first-line treatment for{" "}
<i>Mycoplasma pneumoniae</i>.
</p>
<h3 className="text-2xl font-bold"><strong>Treatment Options</strong></h3>
<h3 className="text-2xl font-bold">
<strong>Treatment Options</strong>
</h3>
<p className="text-justify">
First-Line Antibiotics: Macrolides (e.g., azithromycin, erythromycin) are typically prescribed.
First-Line Antibiotics: Macrolides (e.g., azithromycin, erythromycin)
are typically prescribed.
</p>

<h2 className="text-2xl font-bold">Resources</h2>
<CardGrid data={resources} />
<h2 className="text-2xl font-bold">External Resource</h2>
Expand Down

0 comments on commit 89a2a37

Please sign in to comment.